---
figid: PMC3742001__nihms-459460-f0007
figlink: /pmc/articles/PMC3742001/figure/F7/
number: F7
caption: Schematic diagram summarizing the signaling pathways relevant to this study.
  Activation of receptor tyrosine kinases (RTK) results in the recruitment of the
  adaptor protein insulin receptor substrate (IRS), which results in the activation
  of PI3K-AKT- mammalian target of rapamycin (mTOR) and Ras-Raf-Mek-ERK (extracellular
  signal-regulated kinase) pathways. Serine phosphorylation of IRS on the 636/639
  and 789 residues is associated with reduced signaling from IRS, whereas Y895 phosphorylation
  is associated with enhanced signaling. Blockade of mTOR complex 1 (mTORC1) with
  rapamycin results in the inhibition of S6K, which leads to reduced IRS S636/639
  phosphorylation, enhanced phosphorylation of IRS Y895 residue, and the recruitment
  of the adaptor protein Grb2, resulting in the activation of the ERK pathway. Activated
  ERK1 associates and phosphorylates Nav1.7, leading to hyperexcitability of sensory
  neurons. Activation of adenosine monophosphate-activated protein kinase (AMPK) in
  response to metformin treatment, leads to enhanced IRS S789 phosphorylation (which
  is an inhibitory phospho site) and reduced phosphorylation of IRS Y895 (which is
  a phospho site associated with enhanced IRS activity) residue, which suppresses
  the recruitment of Grb2, thus reversing rapamycin-induced activation of the ERK
  pathway.
pmcid: PMC3742001
papertitle: mTORC1 inhibition induces pain via IRS-1-dependent feedback activation
  of ERK.
reftext: Ohannes K. Melemedjian, et al. Pain. ;154(7):1080-1091.
pmc_ranked_result_index: '33122'
pathway_score: 0.9254854
filename: nihms-459460-f0007.jpg
figtitle: Schematic diagram summarizing the signaling pathways relevant to this study
year: ''
organisms:
- Mus musculus
- Rattus norvegicus
- Armoracia rusticana
- Homo sapiens
- Equus asinus
- Bos taurus
- Oryctolagus cuniculus
ndex: 04a718f0-df0d-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3742001__nihms-459460-f0007.html
  '@type': Dataset
  description: Schematic diagram summarizing the signaling pathways relevant to this
    study. Activation of receptor tyrosine kinases (RTK) results in the recruitment
    of the adaptor protein insulin receptor substrate (IRS), which results in the
    activation of PI3K-AKT- mammalian target of rapamycin (mTOR) and Ras-Raf-Mek-ERK
    (extracellular signal-regulated kinase) pathways. Serine phosphorylation of IRS
    on the 636/639 and 789 residues is associated with reduced signaling from IRS,
    whereas Y895 phosphorylation is associated with enhanced signaling. Blockade of
    mTOR complex 1 (mTORC1) with rapamycin results in the inhibition of S6K, which
    leads to reduced IRS S636/639 phosphorylation, enhanced phosphorylation of IRS
    Y895 residue, and the recruitment of the adaptor protein Grb2, resulting in the
    activation of the ERK pathway. Activated ERK1 associates and phosphorylates Nav1.7,
    leading to hyperexcitability of sensory neurons. Activation of adenosine monophosphate-activated
    protein kinase (AMPK) in response to metformin treatment, leads to enhanced IRS
    S789 phosphorylation (which is an inhibitory phospho site) and reduced phosphorylation
    of IRS Y895 (which is a phospho site associated with enhanced IRS activity) residue,
    which suppresses the recruitment of Grb2, thus reversing rapamycin-induced activation
    of the ERK pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CD
  - PIK3CA
  - PIK3CB
  - PIK3CG
  - PRKAB2
  - IRS4
  - PIK3R4
  - TSC1
  - PRKAA2
  - PRKAG1
  - MAPK1
  - GRB2
  - MAPK3
  - PIK3R3
  - PIK3R5
  - PRKAA1
  - RPTOR
  - NRAS
  - PRKAB1
  - TSC2
  - KRAS
  - MTOR
  - BRAF
  - PIK3R6
  - PRKAG3
  - AKT3
  - AKT1
  - BRD2
  - IRS2
  - ARAF
  - RAF1
  - MAP2K2
  - PRKAG2
  - HRAS
  - MAP2K1
  - IRS1
  - AKT2
  - Metformin
  - Rapamycin
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: TSC1-2
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: TSC1-2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Nat
  symbol: NAT
  source: hgnc_alias_symbol
  hgnc_symbol: BRD2
  entrez: '6046'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
chemicals:
- word: Metformin
  source: MESH
  identifier: D008687
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3742001__F7
redirect_from: /figures/PMC3742001__F7
figtype: Figure
---
